Forian Inc. Reschedules Fourth Quarter and Full Year 2024 Financial Results Announcement

Forian Inc., a prominent data science and analytics solutions provider, has announced a revised date for its fourth quarter and full year 2024 financial results presentation. The company will now release its financial report on Monday, March 31, 2025, after market close, which represents a change from its previous announcement.

Following the financial results release, Forian will host a conference call and webcast at 4:30 p.m. Eastern Time to provide detailed insights into its annual performance. Investors and industry analysts will have the opportunity to gain comprehensive understanding of the company's operational, clinical, and financial metrics across its life sciences, healthcare, and financial services segments.

The rescheduled announcement is significant for stakeholders tracking Forian's strategic developments, particularly in light of the company's recent acquisition of Kyber Data Science. The financial results will offer a holistic view of the organization's growth, market positioning, and potential future trajectories.

Investors and interested parties can access the earnings release, conference call, and webcast replay through Forian's investor relations platform. The company emphasizes transparency by providing multiple channels for accessing the financial information, including live webcast and conference call registration.

The announcement comes with standard forward-looking statements, acknowledging potential risks and uncertainties that could impact future performance. These cautionary notes are typical in financial communications and reflect the complex operational landscape of technology-driven analytics companies.

Forian's strategic focus on data management, information analytics, and cross-industry insights continues to position the company as a significant player in translating complex data into actionable business intelligence. The upcoming financial results presentation will likely provide deeper insights into how the company is leveraging its comprehensive clinical data lake and sophisticated data science capabilities.